SERPING1 and hereditary angioedema: The efficacy of C1INH(IV) (Shire ViroPharma Biologics, Inc.)for LTP was demonstrated in a 24‐week cross‐over study (NCT01005888) of patients with HAE who experienced ≥2 attacks/month.20